Show simple item record

dc.contributor.authorKhezrian, Mina
dc.contributor.authorWaymont, Jennifer
dc.contributor.authorMyint, Phyo K
dc.contributor.authorMcNeil, Christopher J
dc.contributor.authorWhalley, Lawrence
dc.contributor.authorStaff, Roger
dc.contributor.authorMurray, Alison D
dc.date.accessioned2021-01-07T00:12:28Z
dc.date.available2021-01-07T00:12:28Z
dc.date.issued2020-03-01
dc.identifier.citationKhezrian , M , Waymont , J , Myint , P K , McNeil , C J , Whalley , L , Staff , R & Murray , A D 2020 , ' Aspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageing ' , Maturitas , vol. 133 , pp. 49-53 . https://doi.org/10.1016/j.maturitas.2020.01.001en
dc.identifier.issn0378-5122
dc.identifier.otherPURE: 154522349
dc.identifier.otherPURE UUID: 8546f1fb-fca5-4dff-a262-5d837f497f04
dc.identifier.otherScopus: 85077652926
dc.identifier.otherPubMed: 32005423
dc.identifier.otherWOS: 000514004200006
dc.identifier.otherORCID: /0000-0003-4915-4847/work/76976605
dc.identifier.otherunpaywall: 10.1016/j.maturitas.2020.01.001
dc.identifier.otherORCID: /0000-0001-6688-7132/work/99622532
dc.identifier.urihttps://hdl.handle.net/2164/15596
dc.descriptionABC1936 was funded (1999-2009) by the Biotechnology and Biological Sciences Research Council, Scottish Health Department, Wellcome Trust, Medical Research Council, Alzheimer Research UK, Alzheimer Society and University of Aberdeen Development Trust. This work was supported by the Elphinstone Scholarship, Roland Sutton Academic Trust, the Morningfield Association and the Rabin Ezra Scholarship Trust, which provides salary cost and consumables to MK.en
dc.format.extent5
dc.language.isoeng
dc.relation.ispartofMaturitasen
dc.rights© 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectaspirinen
dc.subjectcardiovascular risken
dc.subjectbrain white matter hyperintensityen
dc.subjectcognitionen
dc.subjectolder adultsen
dc.subjectAspirinen
dc.subjectBrain white matter hyperintensityen
dc.subjectCardiovascular risken
dc.subjectCognitionen
dc.subjectOlder adultsen
dc.subjectSMALL VESSEL DISEASEen
dc.subjectDEMENTIAen
dc.subjectPREVENTIONen
dc.subjectCOLLABORATIVE METAANALYSISen
dc.subjectCOGNITIVE FUNCTIONen
dc.subjectDECLINEen
dc.subjectHYPERTENSIONen
dc.subjectWOMENS HEALTHen
dc.subjectREDUCEen
dc.subjectR Medicine (General)en
dc.subjectBiochemistry, Genetics and Molecular Biology(all)en
dc.subjectObstetrics and Gynaecologyen
dc.subjectMedical Research Council (MRC)en
dc.subjectAlzheimers Research UKen
dc.subjectBiotechnology and Biological Sciences Research Council (BBSRC)en
dc.subjectWellcome Trusten
dc.subjectSupplementary Dataen
dc.subjectfileen
dc.subject.lccR1en
dc.titleAspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageingen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Biomedical Imaging Centreen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.maturitas.2020.01.001
dc.date.embargoedUntil2021-01-07
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85077652926&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record